The bill aims to prohibit state agencies, counties, cities, and towns in Washington from purchasing opioid overdose reversal medications from entities that have been involved in settlements with state governments regarding their role in the opioid epidemic. It establishes a new section in chapter 70.14 RCW, which specifies that these entities, including their affiliates and subsidiaries, are ineligible for such purchases unless they have agreed to provide these medications as part of a state settlement prior to September 1, 2024. In that case, they may continue to supply the medications until their settlement obligations are met.

Additionally, the bill mandates the Department of Health to maintain a publicly accessible list of entities that are barred from selling opioid overdose reversal medications to state and local governments. The definition of "opioid overdose reversal medication" is aligned with existing law as outlined in RCW 69.41.095. This legislation reflects the state's commitment to ensuring that public funds are not used to support companies that have contributed to the opioid crisis.